StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Glucotrack's operating income for the twelve months ending Jun 30, 2026 was -$15.40M. For fiscal 2025 it was -$16.09M. The highest annual figure on record is $10.58M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$16.09M–
FY2024Dec 31, 2024-$14.55M–
FY2023Dec 31, 2023-$7.10M–
FY2022Dec 31, 2022-$4.43M–
FY2021Dec 31, 2021-$4.04M–
FY2020Dec 31, 2020-$3.13M-189.3%
FY2019Dec 31, 2019$3.51M–
FY2018Dec 31, 2018-$6.54M-161.8%
FY2017Dec 31, 2017$10.58M–
FY2016Dec 31, 2016-$5.66M–
FY2015Dec 31, 2015-$4.66M–
FY2014Dec 31, 2014-$3.61M–
FY2013Dec 31, 2013-$3.03M–
FY2012Dec 31, 2012-$2.77M–
FY2011Dec 31, 2011-$2.33M–
FY2010Dec 31, 2010-$1.39M–
FY2009Dec 31, 2009-$1.17M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$3.40M–
Q1 FY2026Mar 31, 2026-$4.20M–
Q4 FY2025Dec 31, 2025-$3.49M–
Q3 FY2025Sep 30, 2025-$4.31M–
Q2 FY2025Jun 30, 2025-$4.80M–
Q1 FY2025Mar 31, 2025-$3.50M–
Q4 FY2024Dec 31, 2024-$3.85M–
Q3 FY2024Sep 30, 2024-$3.25M–
Q2 FY2024Jun 30, 2024-$4.49M–
Q1 FY2024Mar 31, 2024-$2.95M–
Q4 FY2023Dec 31, 2023-$2.42M–
Q3 FY2023Sep 30, 2023-$2.22M–
Q2 FY2023Jun 30, 2023-$1.18M–
Q1 FY2023Mar 31, 2023-$1.28M–
Q4 FY2022Dec 31, 2022-$1.29M–
Q3 FY2022Sep 30, 2022-$929.00K–
Q2 FY2022Jun 30, 2022-$1.12M–
Q1 FY2022Mar 31, 2022-$1.09M–
Q4 FY2021Dec 31, 2021-$1.50M–
Q3 FY2021Sep 30, 2021-$767.00K–
Q2 FY2021Jun 30, 2021-$873.00K–
Q1 FY2021Mar 31, 2021-$896.00K–
Q4 FY2020Dec 31, 2020-$878.00K-113.7%
Q3 FY2020Sep 30, 2020-$887.00K–
Q2 FY2020Jun 30, 2020-$611.00K–
Q1 FY2020Mar 31, 2020-$756.00K-173.8%
Q4 FY2019Dec 31, 2019$6.41M–
Q3 FY2019Sep 30, 2019-$980.47K–
Q2 FY2019Jun 30, 2019-$894.31K–
Q1 FY2019Mar 31, 2019$1.03M-46.3%
Q4 FY2018Dec 31, 2018-$1.01M-105.5%
Q3 FY2018Sep 30, 2018-$1.61M–
Q2 FY2018Jun 30, 2018-$2.01M–
Q1 FY2018Mar 31, 2018$1.91M-26.5%
Q4 FY2017Dec 31, 2017$18.47M–
Q3 FY2017Sep 30, 2017-$2.65M–
Q2 FY2017Jun 30, 2017-$2.65M–
Q1 FY2017Mar 31, 2017$2.60M–
Q4 FY2016Dec 31, 2016-$1.32M–
Q3 FY2016Sep 30, 2016-$1.49M–

More Glucotrack figures

See a number that looks wrong?